Treatment of movement disorders by a combined use of chemodenervating agent and automated movement therapy
First Claim
1. A chemodenervating agent which is administered to a patient in an effective amount to treat a movement disorder in the patient, wherein the patient is a patient who is, has been and/or will be subjected to a muscle stimulation therapy, and wherein the chemodenervating agent is administered prior to and/or during and/or after the muscle stimulation therapy.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a method of treating a movement disorder in a patient, the method comprising administering a medicament comprising an effective amount of chemodenervating agent to the patient, wherein the patient is subjected to a muscle stimulation therapy, for example an movement therapy or an muscle activation therapy, and the medicament is administered prior to and/or during and/or after the movement therapy and a kit for the treatment of patients suffering from movement disorders comprising a medicament comprising an effective amount of a chemodenervating agent, and a device for carrying out automated movement therapy.
72 Citations
64 Claims
- 1. A chemodenervating agent which is administered to a patient in an effective amount to treat a movement disorder in the patient, wherein the patient is a patient who is, has been and/or will be subjected to a muscle stimulation therapy, and wherein the chemodenervating agent is administered prior to and/or during and/or after the muscle stimulation therapy.
- 11. A method of treating a movement disorder in a patient, the method comprising administering a composition comprising an effective amount of a chemodenervating agent to the patient, wherein the patient is a patient who is, has been and/or will be subjected to a muscle stimulation therapy, and wherein the chemodenervating agent is administered prior to and/or during and/or after the muscle stimulation therapy.
-
57. The method of claim 57, wherein the botulinum toxin is selected from the group consisting of serotypes A, B, C, D, E, F, G and a mixture thereof.
-
60. A kit for the treatment of patients suffering from movement disorders comprising,
a) a medicament comprising an effective amount of a chemodenervating agent; - and
b) means for carrying out a muscle stimulation therapy. - View Dependent Claims (61, 62, 63, 64)
- and
Specification